Document is current
Any future updates will be listed below
-
Authors
Khalatbari-Soltani, Saman https://orcid.org/0000-0001-8437-1906
Imamura, Fumiaki
Brage, Soren
De Lucia Rolfe, Emanuella
Griffin, Simon J
Wareham, Nicholas J
Marques-Vidal, Pedro
Forouhi, Nita G
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P1LAP3-171805, 33CS30-148401)
Faculty of Biology and Medicine of Lausanne (33CS30-139468)
GlaxoSmithKline (33CSCO-122661)
Medical Research Council (SJAG/004 RG71153, MC_UU_12015/1, MC_UU_12015/5)
National Institute for Health Research (IS-BRC-1215-20014)
- License Information
-
More Information
Article History
Received: 16 August 2018
Accepted: 4 January 2019
First Online: 24 January 2019
Ethics approval and consent to participate
: The Fenland Study was approved by the Cambridge Local Research Ethics Committee (NRES Committee East of England-Cambridge Central – 04/Q0108/19). The institutional Ethics Committee of the University of Lausanne, which later became the Ethics Commission of Canton Vaud () approved the CoLaus study (reference 16/03). Both studies were performed in agreement with the Helsinki declaration and its former amendments. Informed consent was obtained from all participants in both studies.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
